摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,6-di-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-one | 84227-39-4

中文名称
——
中文别名
——
英文名称
1,6-di-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-one
英文别名
8-Methyl-1,6-dipropylimidazo[1,5-d][1,2,4]triazin-4(3H)-one;8-methyl-1,6-dipropyl-3H-imidazo[1,5-d][1,2,4]triazin-4-one
1,6-di-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-one化学式
CAS
84227-39-4
化学式
C12H18N4O
mdl
——
分子量
234.301
InChiKey
GYRNWWWCIUGQRS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    59.3
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    PAUL, R.;BROCKMAN, J. A.;HALLETT, W. A.;HANIFIN, J. W.;TARRANT, M. E.;TOR+, J. MED. CHEM., 1985, 28, N 11, 1704-1716
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agents
    摘要:
    By using inhibition of histamine release from antigen-challenged, sensitized human basophils as a means of identifying a potentially prophylactic drug for the treatment of asthma, a series of substituted imidazo[1,5-d][1,2,4]triazines were found, which were active. These compounds were prepared by treating imidazolecarboxaldehydes with excess Grignard agent and then oxidizing the resulting alcohols to ketones with Jones reagent. Pyrolysis of a mixture of ketone and methyl carbazate at 200 degrees C in diphenyl ether produced the desired imidazo[1,5-d][1,2,4]triazines. Those compounds with the greatest basophil activity were tested for in vivo activity in the mouse passive cutaneous anaphylaxis (PCA) and the guinea pig passive anaphylaxis tests. The best compounds, 1-ethyl-8-methyl-6-propylimidazo[1,5-d][1,2,4]triazin-4(3H)- one (4-17) and 1,8-dimethyl-6-propylimidazo[1,5-d][1,2,4]triazin-4-(3H)-one (4-16) were chosen for further study.
    DOI:
    10.1021/jm00149a029
点击查看最新优质反应信息

文献信息

  • Process for preparing
    申请人:American Cyanamid Co.
    公开号:US04395547A1
    公开(公告)日:1983-07-26
    This disclosure describes a novel process for the preparation of 1-(lower alkyl)substituted derivatives of 6-n-propyl-8-alkylimidazo[1,5-d]-as-triazin-4(3H)-ones which are useful as anti-asthmatic agents.
    本公开描述了一种新颖的制备1-(较低烷基)取代的6-n-丙基-8-烷基咪唑并三唑并[1,5-d]-嘧啶-4(3H)-酮衍生物的过程,这些衍生物可用作抗哮喘药物。
  • Substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4-(3H)-ones
    申请人:American Cyanamid Company
    公开号:US04447603A1
    公开(公告)日:1984-05-08
    This disclosure describes new compounds and compositions of matter useful as anti-asthmatic agents and the method of meliorating asthma in mammals therewith, the novel active ingredients of said compositions of matter being certain 1-substituted-6-n-propyl-8-methylimidazo [1,5-d]-as-triazin-4(3H)-ones and/or the pharmacologically acceptable acid-addition salts thereof.
    本公开说明了一些新化合物和物质组成,这些化合物和物质组成可用作抗哮喘剂,并且使用这些化合物和物质组成的方法可以改善哺乳动物的哮喘病情。这些物质组成的新活性成分是某些1-取代-6-正丙基-8-甲基咪唑[1,5-d]-嘧啶-4(3H)-酮和/或其药理学上可接受的酸加成盐。
  • 1-Substituted-6-n-propyl-8-methylimidazo(1,5-d)-as-triazin-4(3H)-ones
    申请人:AMERICAN CYANAMID COMPANY
    公开号:EP0057289A1
    公开(公告)日:1982-08-11
    This disclosure describes new compounds and compositions of matter useful as anti-asthmatic agents and the method of meliorating asthma in mammals therewith, the novel active ingredients of said compositions of matter being certain 1-substituted-6-n-propyl-8-methylimidazo [1,5-d]-as-triazin-4(3H)-ones and/or the pharmacologically acceptable acid-addition salts thereof.
    本公开描述了可用作抗哮喘药的新化合物和物质组合物,以及用其改善哺乳动物哮喘的方法,所述物质组合物的新活性成分是某些 1-取代-6-正丙基-8-甲基咪唑并[1,5-d]-异三嗪-4(3H)-酮和/或其药理上可接受的酸加成盐。
  • Process for preparing 1-substituted-6-n-propyl-8-methylimidazo(1,5-d)-as-triazin-4(3H)-ones
    申请人:AMERICAN CYANAMID COMPANY
    公开号:EP0085756A1
    公开(公告)日:1983-08-17
    This disclosure describes novel processes for the preparation of 2-(n-propyll-4-methyl-5-(lower alkanoyl) imidazoles which are useful as intermediates for the preparation of anti-asthmatic agents.
    本公开介绍了制备 2-(正丙基-4-甲基-5-(低级烷酰基)咪唑的新工艺,这些咪唑可用作制备抗哮喘药物的中间体。
  • US4395547A
    申请人:——
    公开号:US4395547A
    公开(公告)日:1983-07-26
查看更多